
Eagle Pharmaceuticals EGRX
Quartalsbericht 2023-Q2
hinzugefügt 08.08.2023
Eagle Pharmaceuticals P/E 2011-2026 | EGRX
P/E Jährlich Eagle Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.54 | -69.5 | 52.5 | 52.7 | 19.3 | 17.2 | 12.6 | 426 | -7.09 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 426 | -69.5 | 57.1 |
P/E anderer Aktien in der Arzneimittelhersteller
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Evoke Pharma
EVOK
|
-0.024 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-1.97 | - | -0.1 % | $ 2.03 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
-1.71 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
-1.15 | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-0.679 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
-4.35 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
-0.0895 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
-5.04 | - | - | $ 142 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-60.1 | $ 5.47 | -1.08 % | $ 81.3 M | ||
|
Cronos Group
CRON
|
-254 | $ 2.74 | 2.43 % | $ 1.05 B | ||
|
Harrow Health
HROW
|
-376 | $ 32.24 | 4.46 % | $ 1.19 B | ||
|
Athenex
ATNX
|
-0.111 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-14.7 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
-10.4 | - | - | $ 11.5 B | ||
|
HEXO Corp.
HEXO
|
-0.775 | - | 2.45 % | $ 38.1 M | ||
|
Organogenesis Holdings
ORGO
|
9.11 | $ 2.61 | 2.16 % | $ 331 M | ||
|
Pacira BioSciences
PCRX
|
-11.8 | $ 23.59 | 2.57 % | $ 1.09 B | ||
|
Endo International plc
ENDP
|
-0.0278 | - | - | $ 28.9 M | ||
|
Bausch Health Companies
BHC
|
-5.71 | $ 5.41 | -1.46 % | $ 1.97 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
-1.06 | $ 1.05 | -1.87 % | $ 1.3 M | ||
|
Canopy Growth Corporation
CGC
|
-0.237 | $ 1.08 | 4.37 % | $ 116 M | ||
|
Solid Biosciences
SLDB
|
-3.57 | $ 6.54 | 1.08 % | $ 572 M | ||
|
Aurora Cannabis
ACB
|
141 | $ 3.55 | 2.41 % | $ 195 M | ||
|
Jupiter Wellness
JUPW
|
-0.0479 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
-0.108 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
-3.31 | $ 1.12 | 4.67 % | $ 107 M | ||
|
Tilray
TLRY
|
-0.821 | $ 5.43 | 0.37 % | $ 3.36 B | ||
|
cbdMD
YCBD
|
-1.75 | $ 0.77 | 4.21 % | $ 3.1 M | ||
|
Evolus
EOLS
|
-5.26 | $ 6.49 | -1.59 % | $ 418 M | ||
|
Sundial Growers
SNDL
|
-0.00386 | $ 1.47 | 1.74 % | $ 3.37 M | ||
|
Emergent BioSolutions
EBS
|
-0.182 | $ 8.29 | 1.41 % | $ 424 M | ||
|
Veru
VERU
|
-3.74 | $ 2.19 | 0.92 % | $ 32.1 M | ||
|
Neoleukin Therapeutics
NLTX
|
-0.0473 | - | - | $ 193 M | ||
|
Assertio Holdings
ASRT
|
-2.48 | $ 23.43 | -0.06 % | $ 150 M | ||
|
ProPhase Labs
PRPH
|
7.07 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
-5.6 | - | - | $ 1.42 B | ||
|
PetIQ
PETQ
|
186 | - | 1.64 % | $ 400 M | ||
|
Relmada Therapeutics
RLMD
|
-4.3 | $ 7.28 | 1.53 % | $ 287 M | ||
|
Recro Pharma
REPH
|
-10 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
-5.4 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
-4.41 | $ 0.69 | 3.46 % | $ 34.5 M | ||
|
PLx Pharma
PLXP
|
-2.59 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
336 | $ 16.39 | -1.24 % | $ 19.1 B | ||
|
Zomedica Corp.
ZOM
|
-3.97 | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
-0.536 | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
-6.36 | $ 0.8 | -2.37 % | $ 28.8 M | ||
|
Tricida
TCDA
|
-2.31 | - | - | $ 3.25 M | ||
|
China Pharma Holdings
CPHI
|
-0.862 | $ 0.7 | -7.02 % | $ 3 M | ||
|
TherapeuticsMD
TXMD
|
-40.5 | $ 2.06 | -0.96 % | $ 23.8 M |